A guide to managing your metastatic non-small cell lung cancer patient on KEYTRUDA® (pembrolizumab) plus chemotherapy

Prescribing Information (Great Britain) & Prescribing Information (Northern Ireland) [External links]

Prescribing Information (Great Britain) & Prescribing Information (Northern Ireland) [External links]

PPTX, 5.76 MB

Download this Patient Management Guide powerpoint for information on KEYTRUDA plus chemotherapy in first-line, metastatic non-small cell lung cancer (NSCLC), practicalities of administration and the management of KEYTRUDA plus chemotherapy adverse events.

More information about KEYTRUDA in metastatic NSCLC:

Supporting documentation

Prescribing Information (Great Britain) & Prescribing Information (Northern Ireland) 
By clicking the links above you will leave the MSD Connect website and be taken to the emc PI portal website